|
COMMERCE BUSINESS DAILY ISSUE OF SEPTEMBER 19,1996 PSA#1683National Cancer Institute, Research Contracts Branch, TCS 6120
Executive Blvd, EPS/RM 603Bethesda, MD 20892-7220 A -- PATHOLOGY & VETERINARY SUPPORT SERVICES SOL NCI-CM-77027-30 DUE
112296 POC Elsa B Carlton, Contract Specialist, 301-496-8620 or Therese
M Dick, Contracting Officer, 301-496-8620. The National Cancer
Institute (NCI), Division of Cancer Treatment, Diagnosis and Centers
(DCTDC), Developmental Therapeutics Program (DTP) anticipates the award
of one (1), cost-reimbursement contract, for a 5 year period, beginning
on or about July 30, 1997. As a minimum requirement, the contractors
must comply with the FDA's current Good Laboratory Practice Regulations
(GLPs). The proposed awarded contract will be administrated on a work
assignment managed basis. Work assignments will be issued under the
proposed, level of effort, contract resulting from this solicitation.
DTP is seeking organizations to perform a variety of pathology and
veterinary services to support the DTP preclinical toxicology and
pharmacology program for anticancer and anti-AIDS drug development. The
organization should have the facilities and staff to carry out the
requested efforts and the management expertise to respond to the
diverse and changing needs of this project. Specifically, the work
assignments to be issued will involve the following: operation of a
repository to hold the pathology materials and raw data generated in
past and future toxicology studies; storage of data on optical medium;
performance of an independent verification (peer review) of the
pathological findings by the study pathologist especially with respect
to individual diagnoses, drug-relatedness, nomenclature and slide
quality; provide a pathology support program to prepare blocks and
slides and conduct histopathological evaluation of tissues; perform the
site visits to conduct necropsies, slide preparation or to assist the
Project Officer in project evaluation. This includes providing
expertise in special techniques to assess cardiotoxicity,
neurotoxicity, nephrotoxicity, etc.; storage, maintenance and shipment
of Government infusion equipment to other DTP contractors; development
and implementation of new surgical or other procedures for drug
administration or sampling; instruction in these procedures; or
performance of these procedures in actual animal studies; conduct site
visits to the DTP toxicology contractor laboratories to evaluate
pathology laboratories, animal care programs or to investigate
pathology or animal care problems; and to support the Toxicology and
Pharmacology Branch toxicology efforts required through the preparation
of study protocols, study monitoring and report evaluation. The
Principal Investigator should be a board certified veterinary
pathologist or veterinarian with at least three years experience with
similar programs. This is recompetition of a contract performing these
activities. The Request for Proposal will be available on or about
October 3, 1996. No collect calls will be accepted. (0261) Loren Data Corp. http://www.ld.com (SYN# 0003 19960918\A-0003.SOL)
A - Research and Development Index Page
|
|